254 related articles for article (PubMed ID: 33313798)
41. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
[TBL] [Abstract][Full Text] [Related]
42. Average IGF-1 Prediction for Once-Weekly Lonapegsomatropin in Children With Growth Hormone Deficiency.
Lin Z; Shu AD; Bach M; Miller BS; Rogol AD
J Endocr Soc; 2022 Jan; 6(1):bvab168. PubMed ID: 34913019
[TBL] [Abstract][Full Text] [Related]
43. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
[TBL] [Abstract][Full Text] [Related]
44. Do growth hormone (GH) serial sampling, insulin-like growth factor-I (IGF-I) or auxological measurements have an advantage over GH stimulation testing in predicting the linear growth response to GH therapy?
Rogol AD; Blethen SL; Sy JP; Veldhuis JD
Clin Endocrinol (Oxf); 2003 Feb; 58(2):229-37. PubMed ID: 12580940
[TBL] [Abstract][Full Text] [Related]
45. Pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient children.
Kemp SF; Fielder PJ; Attie KM; Blethen SL; Reiter EO; Ford KM; Marian M; Dao LN; Lee HJ; Saenger P
J Clin Endocrinol Metab; 2004 Jul; 89(7):3234-40. PubMed ID: 15240597
[TBL] [Abstract][Full Text] [Related]
46. Population pharmacokinetic/pharmacodynamic analysis of PEG-rhGH enhances confidence in exploring dosing schemes with longer intervals.
Cheng R; Zhao Q; Zhong G; Xu J; Zheng Z; Xi L; Zhang M; Ni J; Hu P; Luo F; Lu W
Eur J Pharm Sci; 2022 Dec; 179():106304. PubMed ID: 36209987
[TBL] [Abstract][Full Text] [Related]
47. Weekly somapacitan had no adverse effects on glucose metabolism in adults with growth hormone deficiency.
Takahashi Y; Biller BMK; Fukuoka H; Ho KKY; Rasmussen MH; Nedjatian N; Sværke C; Yuen KCJ; Johannsson G
Pituitary; 2023 Feb; 26(1):57-72. PubMed ID: 36380045
[TBL] [Abstract][Full Text] [Related]
48. European audit of current practice in diagnosis and treatment of childhood growth hormone deficiency.
Juul A; Bernasconi S; Clayton PE; Kiess W; DeMuinck-Keizer Schrama S;
Horm Res; 2002; 58(5):233-41. PubMed ID: 12401943
[TBL] [Abstract][Full Text] [Related]
49. Somapacitan: a long-acting growth hormone derivative for treatment of growth hormone deficiency.
Paton DM
Drugs Today (Barc); 2022 Oct; 58(10):509-517. PubMed ID: 36305544
[TBL] [Abstract][Full Text] [Related]
50. The insulin-like growth factor-I (IGF-I) generation test as an indicator of growth hormone status.
Spiliotis BE; Alexandrides TK; Karystianos C; Vassilakos P; Zadik Z; Nikolakopoulou NM; Nikiforidis G; Beratis NG
Hormones (Athens); 2009; 8(2):117-28. PubMed ID: 19570739
[TBL] [Abstract][Full Text] [Related]
51. Insulin-like growth factor I and growth responses during the first year of growth hormone treatment in KIGS patients with idiopathic growth hormone deficiency, acquired growth hormone deficiency, turner syndrome and born small for gestational age.
Cutfield WS; Lundgren F
Horm Res; 2009 Jan; 71 Suppl 1():39-45. PubMed ID: 19153504
[TBL] [Abstract][Full Text] [Related]
52. National Cooperative Growth Study substudy VI: the clinical utility of growth-hormone-binding protein, insulin-like growth factor I, and insulin-like growth factor-binding protein 3 measurements.
Attie KM; Julius JR; Stoppani C; Rundle AC
J Pediatr; 1997 Jul; 131(1 Pt 2):S56-60. PubMed ID: 9255230
[TBL] [Abstract][Full Text] [Related]
53. MOD-4023, a long-acting carboxy-terminal peptide-modified human growth hormone: results of a Phase 2 study in growth hormone-deficient adults.
Strasburger CJ; Vanuga P; Payer J; Pfeifer M; Popovic V; Bajnok L; Góth M; Olšovská V; Trejbalová L; Vadasz J; Fima E; Koren R; Amitzi L; Bidlingmaier M; Hershkovitz O; Hart G; Biller BMK
Eur J Endocrinol; 2017 Mar; 176(3):283-294. PubMed ID: 27932411
[TBL] [Abstract][Full Text] [Related]
54. Relevance of IGF-I, IGFBP-3, and IGFBP-2 measurements during GH treatment of GH-deficient and non-GH-deficient children and adolescents.
Ranke MB; Schweizer R; Elmlinger MW; Weber K; Binder G; Schwarze CP; Wollmann HA
Horm Res; 2001; 55(3):115-24. PubMed ID: 11549872
[TBL] [Abstract][Full Text] [Related]
55. A reversible albumin-binding growth hormone derivative is well tolerated and possesses a potential once-weekly treatment profile.
Rasmussen MH; Olsen MW; Alifrangis L; Klim S; Suntum M
J Clin Endocrinol Metab; 2014 Oct; 99(10):E1819-29. PubMed ID: 25013997
[TBL] [Abstract][Full Text] [Related]
56. Dose-sparing and safety-enhancing effects of an IGF-I-based dosing regimen in short children treated with growth hormone in a 2-year randomized controlled trial: therapeutic and pharmacoeconomic considerations.
Cohen P; Weng W; Rogol AD; Rosenfeld RG; Kappelgaard AM; Germak J
Clin Endocrinol (Oxf); 2014 Jul; 81(1):71-6. PubMed ID: 24428305
[TBL] [Abstract][Full Text] [Related]
57. Increases in Bioactive IGF do not Parallel Increases in Total IGF-I During Growth Hormone Treatment of Children Born SGA.
Wegmann MG; Jensen RB; Thankamony A; Frystyk J; Roche E; Hoey H; Kirk J; Shaikh G; Ivarsson SA; Söder O; Dunger DB; Juul A
J Clin Endocrinol Metab; 2020 Apr; 105(4):. PubMed ID: 31665326
[TBL] [Abstract][Full Text] [Related]
58. The role of insulin like growth factor (IGF)-1 and IGF-binding protein-3 in diagnosis of Growth Hormone Deficiency in short stature children.
Haghshenas Z; Sotoudeh K; Karamifar H; Karamizadeh Z; Amirhakimi G
Indian J Pediatr; 2009 Jul; 76(7):699-703. PubMed ID: 19381505
[TBL] [Abstract][Full Text] [Related]
59. Pharmacokinetic and pharmacodynamic profile of a new sustained-release GH formulation, LB03002, in children with GH deficiency.
Peter F; Savoy C; Ji HJ; Juhasz M; Bidlingmaier M; Saenger P
Eur J Endocrinol; 2009 Mar; 160(3):349-55. PubMed ID: 19074465
[TBL] [Abstract][Full Text] [Related]
60. A Bayesian Approach to Diagnose Growth Hormone Deficiency in Children: Insulin-Like Growth Factor Type 1 Is Valuable for Screening and IGF-Binding Protein Type 3 for Confirmation.
Inoue-Lima TH; Vasques GA; Nakaguma M; Brito LP; Mendonça BB; Arnhold IJP; Jorge AAL
Horm Res Paediatr; 2020; 93(3):197-205. PubMed ID: 32799208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
